China Healthcare News

Medical breakthroughs, surgical innovation, drug development, and health technology from China's top hospitals

Latest Updates

Neonatology

A Rogue Immune Cell Drives Deadly Newborn Intestine Disease — And Blocking Its Metabolism Saves Lives

June 21, 2026

Necrotizing enterocolitis (NEC) strikes without warning in premature infants, destroying portions of the intestine within hours. A groundbreaking Nature Communications study from Guangdong Provincial People's Hospital and Southern Medical University identifies DN ILC3s as the rogue immune cell driving NEC, and shows that blocking Atg5-mediated autophagy or supplementing phosphatidylcholine can tame the inflammatory destruction.

Oncology

One Pill, 83% Fewer Recurrences: Chinese-Led Trial Rewrites the Rulebook for Rare Lung Cancer After Surgery

June 21, 2026

A global Phase III trial led by Professor Yi-Long Wu of Guangdong Provincial People's Hospital — published in the New England Journal of Medicine — demonstrates that adjuvant selpercatinib reduces recurrence by 83% in stage II–IIIA RET fusion-positive NSCLC after curative surgery, establishing the first targeted therapy for this rare molecular subtype.

Cardiology

World First: Engineered Immune Cells Simultaneously Clear Heart Scar Tissue and Regenerate Muscle After Heart Attack

June 21, 2026

Qilu Hospital of Shandong University researchers have engineered CAR-monocytes (pCAR-Mos) that simultaneously clear cardiac scar tissue and regenerate heart muscle after myocardial infarction — a world-first breakthrough published in Cell Stem Cell.

Gene Therapy

Single AAV9 Dose Replaces Lifelong Enzyme Therapy for Pompe Disease — 301 Hospital Gene Therapy Breakthrough Published in NEJM

June 20, 2026

A single intravenous dose of AAV9 gene therapy at Beijing's 301 Hospital has eliminated the need for lifelong enzyme replacement therapy in infantile-onset Pompe disease, with durable enzyme expression and clinical improvement published in The New England Journal of Medicine.

Hematology

Low-Dose NMN Reverses Immune Thrombocytopenia — Tianjin Hematology Hospital Discovers Metabolic Path to Platelet Recovery

June 20, 2026

A clinical trial published in Nature Medicine demonstrates that low-dose oral NMN restores platelet counts in ITP patients by correcting a metabolic defect in megakaryocytes — the first evidence that a metabolic supplement can treat an autoimmune disease by rescuing the target cell rather than suppressing the immune system.

Neurology

Adding Ticagrelor to Aspirin After Clot-Busting Therapy Improves Stroke Recovery — Tiantan Hospital TAPIS Trial Published in The Lancet

June 20, 2026

The TAPIS trial from Beijing Tiantan Hospital, published in The Lancet, demonstrates that starting ticagrelor plus aspirin within hours after intravenous thrombolysis significantly improves 90-day functional outcomes in acute ischemic stroke patients without increasing symptomatic intracranial hemorrhage risk.

Cardiology

Engineered Immunosuppressive Dendritic Cells Reverse Cardiac Fibrosis — SAHZU Team Achieves First Primate Validation

June 18, 2026

SAHZU researchers have achieved a world-first by using engineered immunosuppressive dendritic cells (iCDCs) to reverse cardiac fibrosis in non-human primates. Published in Nature, this breakthrough could transform post-heart attack treatment globally.

Cardiology

Magnetofluid Left Atrial Appendage Occlusion — Fuwai Hospital and SIAT Invent Liquid-Based Alternative to Watchman

June 18, 2026

Fuwai Hospital and SIAT have developed a revolutionary magnetofluid-based left atrial appendage occlusion system that uses a magnetically controlled liquid instead of metal devices, offering a reversible, custom-conforming solution for stroke prevention in atrial fibrillation patients.

Pediatrics

Gut Commensal Bile Acid Saves Children From Sepsis — Chinese Team Discovers Microbiome Metabolite That Blocks Deadly Immune Storm

June 18, 2026

Chinese researchers discover a sulfated bile acid produced by gut commensal Bacteroides that dramatically protects against pediatric sepsis by modulating the immune response. Published in Nature Microbiology, this breakthrough offers a new microbiome-based approach to treating childhood sepsis.

Orthopedics

Autologous Bone Tissue Bank 'Store First, Use Later' — West China Hospital Breakthrough

June 17, 2026

West China Hospital pioneers autologous bone tissue banking using -196°C cryopreservation technology, enabling patients to store their own bone for future surgeries. A 68-year-old patient successfully underwent revision hip replacement using her own femoral head stored 60 days earlier.

Immunology

H3K23ac Epigenetic Programming Reverses Immune Aging

June 17, 2026

Researchers at West China Hospital, Sichuan University identified H3K23 acetylation as a key epigenetic mechanism driving immune aging and demonstrated that small molecule intervention can restore youthful immune function. Published in Nature Cell Biology, May 2026.

Cardiology

REFORM-TAD International Multicenter Clinical Trial for Type A Aortic Dissection

June 17, 2026

West China Hospital enrolls first global patient in REFORM-TAD trial, testing a breakthrough endovascular stent system that could reduce long-term complications by 70% for patients with residual aortic dissection after initial surgery.

Neurology

Remote Programming for Deep Brain Stimulation Reduces Healthcare Inequality by 30%, Landmark Study Finds

June 16, 2026

A landmark study published in Nature Health demonstrates that remote programming for deep brain stimulation devices delivers clinical outcomes matching in-person care while reducing healthcare inequality by 30%.

Neurology

Chinese Scientists Discover Parkinson's Disease Gene and AI-Identified Drug Candidate

June 16, 2026

Shanghai's Huashan Hospital team identifies FAM171A2 as the molecular gateway for Parkinson's disease spread and uses AI to find bemcentinib as a blocking drug. Published on the cover of Science.

Transplant Surgery

World-First Gene-Edited Pig Liver and Kidney Transplants: Xijing Hospital's Xenotransplantation Breakthroughs

June 16, 2026

Xijing Hospital in Xi'an achieves world-first gene-edited pig liver and kidney transplants, keeping a pig kidney functioning for over 261 days in a living recipient. Published in Nature and Nature Medicine.

Neuro-Oncology

One Microliter Detects Brain Cancer: PKU Third Hospital's Zeptomolar Biosensor Revolutionizes Glioma Diagnosis

June 15, 2026

Peking University Third Hospital develops zeptomolar biosensor detecting glioma ctDNA in 1µL CSF with 93.33% sensitivity and zero false negatives, published in Advanced Science (IF 14.1).

Cardiology

From 'Heart-Brain Dilemma' to 'Heart-Brain Co-Treatment': PUMCH Redefines Surgery for Infective Endocarditis with Brain Complications

June 15, 2026

Peking Union Medical College Hospital publishes landmark study in JAHA, providing the first evidence-based framework for surgical timing in infective endocarditis with brain complications, reducing mortality from 45% to 8.8%.

Gastroenterology

World's First Single-Cell Atlas of Severe Pancreatitis Reveals TNF-α as Key Therapeutic Target — Zhejiang University Study Published in Gut

June 15, 2026

Zhejiang University researchers build the world's first human single-cell atlas of severe acute pancreatitis, revealing TNF-α drives microcirculatory dysfunction via CD8+ T cell-mediated endothelial injury. Published in Gut (IF 23.1).

Orthopedics

Nanogene Hydrogel Rejuvenates Aging Cartilage in Osteoarthritis Breakthrough

June 14, 2026

West China Hospital team develops polyphenol-armored gene therapy offering new hope for millions with age-related joint disease

Pulmonology

Pulmonary Fibrosis Vaccine Discovery Opens New Treatment Frontier

June 14, 2026

West China Hospital team identifies antigen targets that could lead to first disease-modifying vaccine for deadly lung condition

Ophthalmology

Groundbreaking Gene Therapy for X-Linked Retinoschisis Published in NEJM

June 14, 2026

West China Hospital achieves first successful clinical trial of gene therapy for inherited retinal disease in top-tier medical journal

Urology

PUMCH and Tsinghua Develop Novel Protein Coating to Solve Ureteral Stent Encrustation and Infection

June 12, 2026

Peking Union Medical College Hospital urology team collaborates with Tsinghua University to create intelligent hydrophilic protective membrane using natural intrinsically disordered protein condensates, solving complications for 1.5 million stents annually.

Oncology

China's Ruijin Hospital Unveils XP-004 Personalized mRNA Vaccine at ASCO 2026: 100% Recurrence-Free in Pancreatic Cancer Trial

June 12, 2026

Shanghai Ruijin Hospital presents Phase I data of XP-004 neoantigen mRNA vaccine at ASCO 2026 Clinical Science Symposium - 16 patients, 100% recurrence-free at 10 months, 100% immune response rate.

Nephrology

Tongji Hospital Nephrology: Over 10 Studies at ERA 2026 Congress — Stem Cell Therapy, Precision IgA Nephropathy Treatment, and Vascular Calcification Breakthroughs

June 12, 2026

Tongji Hospital's nephrology team presents groundbreaking research at ERA 2026, including stem cell therapy for chronic kidney disease, precision treatment for IgA nephropathy, and vascular calcification mechanisms — with over 10 studies accepted at the prestigious European Renal Association congress.

Research Breakthrough

Chinese Researchers Challenge Traditional View: Lacunar Stroke May Not Stem from Large Vessel Narrowing

June 11, 2026

A landmark study by PUMCH neurologists published in Circulation reveals that tortuous and dilated blood vessels, not narrowed arteries, may be the true culprit behind lacunar stroke.

Research Breakthrough

Chinese Researchers Discover Vascular Gate That Blocks Immunotherapy in Aggressive Lung Cancer

June 11, 2026

A groundbreaking discovery by West China Hospital researchers reveals why small cell lung cancer resists immunotherapy - and points to a potential solution using existing drugs.

Research Breakthrough

Chinese Researchers Discover Why Regulatory T Cells Fail in Rheumatoid Arthritis: Iron Overload Triggers Cell Death

June 11, 2026

A groundbreaking discovery by Shanghai Jiao Tong University researchers reveals why regulatory T cells in rheumatoid arthritis joints fail to suppress inflammation - and points to ferroptosis as the key culprit.

Stem Cell Research

Chinese Researchers Discover Reversible Path to Combat Immune Aging - West China Hospital Nature Paper

June 10, 2026

West China Hospital researchers identify Meg3+ stem cells driving immune aging and discover the H3K23ac-TRIM24-PU.1 pathway that can be reversed, opening new possibilities for anti-aging medicine.

Anti-Aging Research

Common Diabetes Drug Metformin Reverses Intestinal Aging - Chinese Academy of Sciences Nature Aging Breakthrough

June 10, 2026

Chinese Academy of Sciences researchers discover that metformin restores NCoR1 levels and reverses intestinal aging in primates, providing molecular mechanism for anti-aging effects.

AI Diagnostics

Revolutionary Eye Scan Detects Kidney Disease - No Biopsy Needed | Sun Yat-sen University Nature Communications Breakthrough

June 10, 2026

Sun Yat-sen University develops AI-powered retinal imaging that diagnoses chronic kidney disease without invasive biopsies, achieving 92.3% sensitivity across 5 pathological types.

Oncology

China's mRNA Vaccine for Pancreatic Cancer: Ruijin Hospital XP-004 Achieves 100% Recurrence-Free Survival

June 9, 2026

Shanghai Ruijin Hospital's XP-004 mRNA vaccine for pancreatic cancer achieves 100% recurrence-free survival in Phase I trial. The innovative KRAS universal antigen plus personalized neoantigen strategy shows promise for immunologically 'cold' tumors.

Endocrinology

Chinese GLP-1 Drug GZR18 Enters Phase 3 Trial for Weight Loss

June 8, 2026

Gan & Lee Pharmaceuticals has initiated a pivotal Phase 3 clinical trial for GZR18, a novel GLP-1/GIP dual agonist for weight management, enrolling 630 participants across multiple hospitals in China.

Oncology

Chinese Drug Beats Keytruda: Ivonescimab Shows 34% Death Risk Reduction in Lung Cancer Trial

June 8, 2026

For the first time in cancer treatment history, a Chinese drug has demonstrated a statistically significant overall survival benefit over standard immunotherapy in first-line NSCLC. Ivonescimab reduced death risk by 34% in the HARMONi-6 trial.

Oncology

Chinese ADC Drug SKB264 Launches Global Phase 3 Trials Across Multiple Cancers

June 8, 2026

Sichuan Kelun-Biotech's SKB264 (sacituzumab tirumotecan), partnered with Merck, now in multiple global Phase 3 trials for breast, lung, and cervical cancer. Over 1,000 patients to be enrolled worldwide.

Cardiology

China's Bioresorbable ASD Occluder: JAMA-Published Breakthrough in Congenital Heart Disease Treatment

June 7, 2026

China develops world's first bioresorbable atrial septal defect occluder, published in JAMA October 2025. 230-patient RCT shows 96.5% success rate and 99.8% degradation at 2 years. Available at Yunnan Fuwai and Beijing Fuwai Hospitals.

Oncology

China Publishes World's First In-Vivo CAR-T Human Trial in The Lancet

June 7, 2026

Chinese researchers publish the world's first human clinical evidence of in-vivo CAR-T therapy in The Lancet, potentially transforming cancer treatment from weeks of hospitalization to a single injection.

Neurology

China's Revolutionary Alzheimer's Blood Test: Early Detection Decades Before Symptoms

June 6, 2026

China's breakthrough in Alzheimer's blood test technology enables early detection 10-20 years before symptoms. Learn about p-tau217 biomarker testing at leading Chinese hospitals.

Gene Therapy

China's Hemophilia B Gene Therapy: A Single Injection That Ends a Lifetime of Bleeding

June 6, 2026

China's first approved hemophilia B gene therapy BBM-H901 (Xinjiuning) offers single-dose cure at 1/9 the cost of US alternatives. Learn about this medical breakthrough.

Medical Tourism

China Medical Tourism 2026: Dental Implants, Vision Correction & Traditional Chinese Medicine

June 5, 2026

China offers dental implants at 60-80% less than Western prices, cutting-edge LASIK/SMILE vision correction, and authentic TCM therapies — all delivered in JCI-accredited hospitals with internationally trained physicians.

Regenerative Medicine

China's Stem Cell Diabetes Breakthrough: Functional Cure Within Reach

June 5, 2026

China pioneers stem cell therapy for diabetes reversal. From Boao Lecheng to 301 Hospital, Chinese researchers achieve functional cure for Type 2 diabetes.

Medical Technology

China's CAR-T Cell Therapy Revolutionizes Cancer Treatment at Fraction of US Cost

June 4, 2026

China has emerged as an unexpected leader in CAR-T cell therapy, offering revolutionary cancer treatment at roughly 15% of US prices, attracting international patients worldwide.

Vaccination

China Launches First Domestic Shingles Vaccine With Massive 50+ Subsidies

June 4, 2026

China's first domestic shingles vaccine Ganwei (感维) and government 'pay one get one free' subsidy programs are making shingles prevention accessible and affordable for millions of seniors.

Medical Technology

No Open Chest, 1 Hour to Replace a Heart Valve - China's TaurusTrio Revolutionizes Aortic Regurgitation Treatment

June 4, 2026

China's TaurusTrio is the first transcatheter device designed specifically for pure aortic regurgitation, enabling valve replacement without open-heart surgery in just 60 minutes.

Global Health

China's Artemisinin - The Nobel Prize Discovery That Saved Millions from Malaria

June 3, 2026

When Chinese scientist Tu Youyou accepted the 2015 Nobel Prize, she represented a discovery that has saved over 6 million lives from malaria since 2000, making artemisinin one of humanity's most significant medical achievements.

Pharmaceutical Innovation

Chinese Pharma Haisco Partners with Eli Lilly in $3.05 Billion Deal: A New Era for China's Global Drug Development

June 2, 2026

Haisco Pharmaceutical Group signs landmark $3.054 billion partnership with Eli Lilly, marking one of the largest international deals for a Chinese drugmaker and signaling global recognition of China's innovative drug development capabilities.

Pharmaceutical Innovation

Chinese Original Anesthesia Drug Cipepofol Receives FDA Approval: A Milestone for China's Pharmaceutical Innovation

June 1, 2026

After 14 years of research and development, Haisco Pharmaceutical Group's innovative intravenous anesthetic Cipepofol becomes the first Chinese original anesthetic drug approved for the U.S. market, benefiting over 40 million patients worldwide.

Vision Health

7-Year Clinical Trial Results Confirm Long-Term Efficacy of Chinese Myopia Control Technology: A Breakthrough for Children's Vision Health

June 1, 2026

At Vision China 2026, researchers from Wenzhou Medical University Eye Hospital presented groundbreaking 7-year follow-up data on H.A.L.T. technology lenses, demonstrating sustained myopia control effectiveness that could transform how millions of Chinese children are protected from progressive nearsightedness.

Medical AI

Chinese AI System DeepRare Achieves Historic Milestone: First to Outperform Human Experts in Rare Disease Diagnosis

May 31, 2026

Chinese researchers have developed DeepRare, the first AI system to consistently outperform human experts in rare disease diagnosis. Published in Nature, the system achieved 78.5% Recall@5 compared to physicians' 65.6%, and when combined with genetic data, improved diagnostic accuracy from 39.9% to 69.1%. For the 300 million people worldwide living with rare diseases, this breakthrough could end the five-year diagnostic odyssey.

Ophthalmology

China's Multi-Glau AI: How a Three-Tier System Is Bringing World-Class Glaucoma Diagnosis to Rural Clinics

May 30, 2026

Chinese researchers have developed Multi-Glau, a three-tier AI system that brings world-class glaucoma diagnosis to rural clinics. Published in npj Digital Medicine, the system achieved 92.54% accuracy in screening and is already deployed across China's hierarchical healthcare system. For the 21 million Chinese citizens with glaucoma, this AI system represents a fundamental shift in what is possible.

Cardiovascular Medicine

China's Wire-Free Revolution: How QFR Technology Is Rewriting the Rules of Coronary Intervention Worldwide

May 29, 2026

Chinese cardiologists have developed QFR — Quantitative Flow Ratio — a wire-free computational technology that measures coronary artery blockage severity from angiogram images alone. The landmark FAVOR III China trial published in The Lancet proved QFR-guided PCI delivers 35% fewer major adverse events at one year. Now deployed across China's major heart centers including Fuwai Hospital and Xijing Hospital, this homegrown innovation is changing how cardiologists worldwide decide which patients need stents.

Medical Tourism

The Foreigner's Guide to Getting a Health Checkup in China: 10x Cheaper Than the US, Done in One Morning

May 29, 2026

A comprehensive guide to full body checkup and executive physical screening in China for international visitors. Complete blood work, CT/MRI imaging, tumor markers, and specialist consultation — all completed in a single morning for $200–$3,000 (vs. $8,000–$20,000 in the US). Covers Shanghai, Beijing, Shenzhen hospital options with pricing tiers, visa-free entry logistics, booking via WeChat, and practical tips for health screening travel.

Reproductive Medicine

Chinese Scientists Identify the Master Switch for Human Embryo Development: The OTX2 Breakthrough Rewriting IVF Science

May 29, 2026

Shandong University researchers identified OTX2 as the master transcription factor that activates the human embryonic genome — a landmark Nature Genetics paper that is already reshaping IVF protocols at China's largest reproductive medicine centers. Covers the science, hospital translation, AI embryo assessment integration, patient impact, IVF costs in China ($4,100–$8,200 vs $15,000–$30,000 in US), and ethical considerations.

Medical Innovation

Goodbye Metal Plates: China's "Bone Glue" Could End Traditional Fracture Surgery

May 28, 2026

Zhejiang University's Sir Run Run Shaw Hospital has developed the world's first bone glue (bone adhesive) — Gu-02 — a minimally invasive fracture treatment that bonds broken bones within minutes, replacing metal plates and screws. This orthopedic innovation has received dual NMPA Innovative Device and FDA Breakthrough Device designations, making it a landmark breakthrough in bone healing technology and China medical device innovation.

Public Health

China's Hepatitis B Vaccine Success Story - A Global Public Health Model That Saved Millions

May 28, 2026

With a 99.6% newborn vaccination rate far exceeding the global average of 85%, China's hepatitis B prevention program has become one of the world's most successful public health initiatives, reducing HBV prevalence in children under five to just 0.30% and preventing millions of future liver cancer deaths.

Medical Technology

Chinese Snake-Arm Single-Port Surgical Robot Saves 11-Year-Old Girl - A New Chapter in Minimally Invasive Surgery

May 28, 2026

When an 11-year-old girl who had already endured six intestinal resection surgeries faced a life-threatening ovarian tumor, traditional surgical approaches seemed impossible due to severe abdominal adhesions. The solution came from a domestically developed snake-arm single-port surgical robot that performed the complex procedure through a single small incision.

Medical Technology

China's Brain-Computer Interface Breakthrough: Giving Voice and Control Back to Paralyzed Patients

July 2, 2025

In 2025, Chinese researchers achieved a world-first: a brain implant that enables paralyzed patients to speak expressively, sing, and control computers with their thoughts. This landmark breakthrough, reported in Nature, positions China at the forefront of neuroprosthetic technology alongside Neuralink.

Medical Breakthrough

Chinese Scientists Cure Type 1 Diabetes: World's First Patient Freed from Insulin Using Her Own Stem Cells

September 25, 2024

Chinese scientists at Shanghai Changzheng Hospital achieved a world-first by curing type 1 diabetes using autologous iPSC-derived islet cells. A 25-year-old woman became insulin-independent within 75 days after receiving 1.5 million stem cell-derived islet cells—without any immunosuppressive drugs.